skip to Main Content
AIM-HI Portfolio Company Yivivia and Its Co-Founder Featured in Yale University Profile

AIM-HI Portfolio Company Yivivia and Its Co-Founder Featured in Yale University Profile

More than 20 years ago, Yale pharmacology professor Yung-Chi Cheng, a leader in drug development for hepatitis B, cancer, and HIV, had a radical idea: What if he could unlock the therapeutic potential of ancient Chinese medicines for treating cancer? What if he could design botanical drugs that would make traditional cancer treatments work better?

Read more: https://news.yale.edu/2020/03/13/ancient-chinese-medicine-unlocks-new-possibilities-cancer-treatment

Back To Top